Speaker illustration

Doctor Maria Rosa Costanzo

Midwest Cardiovascular Institute, Naperville (United States of America)

Member of:

European Society of Cardiology
Heart Failure Association

Maria Rosa Costanzo, MD, Dr. Costanzo received her medical degree summa cum laude from the University of Bologna in Italy. Her postgraduate training included a fellowship in cardiology at Loyola University Medical Center in Maywood, Illinois. Dr. Costanzo is a Fellow of the American College of Cardiology, American Heart Association and European Society of Cardiology. She is also a member of the Ordine Dei Medici (The Italian National Medical Professional Association). Dr. Costanzo served as Medical Director of the Loyola University Chicago Heart failure and Cardiac Transplant Program from 1988 until 1994. From 1994 until 2001 Dr. Costanzo was the Medical Director of the Heart Failure/Cardiac Transplant Program at Rush University Medical Center and was the John H. and Margaret V. Krehbiel Professor of Cardiology at the Rush Medical College. From 1995 until 2000 Dr. Costanzo was the Editor in Chief of the Journal of heart and Lung Transplantation. In 2002 Dr. Costanzo became the Med

Late breaking clinical trials II

Event: Heart Failure 2024

Topic: Heart Failure Association (HFA)

Session type: Late-Breaking Science

Thumbnail

Interatrial shunt devices: a new tool for heart failure treatment?

Event: Heart Failure 2024

Topic: Device Therapy

Session type: Symposium

Thumbnail

New tools to detect and treat acute heart failure

Event: Heart Failure 2024

Topic: Acute Heart Failure

Session type: Rapid Fire Abstracts

Thumbnail

Acute heart failure: prevention and treatment

Event: ESC Congress 2023

Topic: Treatment

Session type: Moderated ePosters

Thumbnail

Insights from recent HFpEF trials 1

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session type: Abstract Sessions

Thumbnail

Myocardial disease - amyloid heart disease

Event: Heart Failure 2023

Topic: Myocardial Disease

Session type: Clinical Cases

Thumbnail

Understanding the role of artificial intelligence in heart failure

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session type: Symposium

Thumbnail

Latest science in heart failure 2

Event: ESC Congress 2022

Topic: Chronic Heart Failure

Session type: Late-Breaking Science

Thumbnail

Chronic heart failure - New treatments and trials

Event: ESC Congress 2022

Topic: Chronic Heart Failure

Session type: Moderated ePosters

Thumbnail

Empagliflozin across the spectrum of ejection fraction in HF ‒ aggregate findings from the EMPEROR programme

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb